Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation

Abstract Immunosuppressive therapy can decrease rejection episodes and increase the risk of severe and fatal infections in heart transplantation (HT) recipients. Immunosuppressive therapy can also decrease the absolute lymphocyte count (ALC), but the relationship between early post-transplant ALC an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Minjae Yoon, Jaewon Oh, Kyeong-Hyeon Chun, Chan Joo Lee, Seok-Min Kang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/550504f146ab437abc7137bee8ec93e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:550504f146ab437abc7137bee8ec93e6
record_format dspace
spelling oai:doaj.org-article:550504f146ab437abc7137bee8ec93e62021-12-02T14:01:35ZPost-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation10.1038/s41598-020-80790-42045-2322https://doaj.org/article/550504f146ab437abc7137bee8ec93e62021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80790-4https://doaj.org/toc/2045-2322Abstract Immunosuppressive therapy can decrease rejection episodes and increase the risk of severe and fatal infections in heart transplantation (HT) recipients. Immunosuppressive therapy can also decrease the absolute lymphocyte count (ALC), but the relationship between early post-transplant ALC and early cytomegalovirus (CMV) infection is largely unknown, especially in HT. We retrospectively analyzed 58 HT recipients who tested positive for CMV IgG antibody and received basiliximab induction therapy. We collected preoperative and 2-month postoperative data on ALC and CMV load. The CMV load > 1200 IU/mL was used as the cutoff value to define early CMV infection. Post-transplant lymphopenia was defined as an ALC of < 500 cells/μL at postoperative day (POD) #7. On POD #7, 29 (50.0%) patients had post-transplant lymphopenia and 29 (50.0%) patients did not. The incidence of CMV infection within 1 or 2 months of HT was higher in the post-transplant lymphopenia group than in the non-lymphopenia group (82.8% vs. 48.3%, P = 0.013; 89.7% vs. 65.5%, P = 0.028, respectively). ALC < 500 cells/μL on POD #7 was an independent risk factor for early CMV infection within 1 month of HT (odds ratio, 4.14; 95% confidence interval, 1.16–14.77; P = 0.029). A low ALC after HT was associated with a high risk of early CMV infection. Post-transplant ALC monitoring is simple and inexpensive and can help identify patients at high risk of early CMV infection.Minjae YoonJaewon OhKyeong-Hyeon ChunChan Joo LeeSeok-Min KangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Minjae Yoon
Jaewon Oh
Kyeong-Hyeon Chun
Chan Joo Lee
Seok-Min Kang
Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
description Abstract Immunosuppressive therapy can decrease rejection episodes and increase the risk of severe and fatal infections in heart transplantation (HT) recipients. Immunosuppressive therapy can also decrease the absolute lymphocyte count (ALC), but the relationship between early post-transplant ALC and early cytomegalovirus (CMV) infection is largely unknown, especially in HT. We retrospectively analyzed 58 HT recipients who tested positive for CMV IgG antibody and received basiliximab induction therapy. We collected preoperative and 2-month postoperative data on ALC and CMV load. The CMV load > 1200 IU/mL was used as the cutoff value to define early CMV infection. Post-transplant lymphopenia was defined as an ALC of < 500 cells/μL at postoperative day (POD) #7. On POD #7, 29 (50.0%) patients had post-transplant lymphopenia and 29 (50.0%) patients did not. The incidence of CMV infection within 1 or 2 months of HT was higher in the post-transplant lymphopenia group than in the non-lymphopenia group (82.8% vs. 48.3%, P = 0.013; 89.7% vs. 65.5%, P = 0.028, respectively). ALC < 500 cells/μL on POD #7 was an independent risk factor for early CMV infection within 1 month of HT (odds ratio, 4.14; 95% confidence interval, 1.16–14.77; P = 0.029). A low ALC after HT was associated with a high risk of early CMV infection. Post-transplant ALC monitoring is simple and inexpensive and can help identify patients at high risk of early CMV infection.
format article
author Minjae Yoon
Jaewon Oh
Kyeong-Hyeon Chun
Chan Joo Lee
Seok-Min Kang
author_facet Minjae Yoon
Jaewon Oh
Kyeong-Hyeon Chun
Chan Joo Lee
Seok-Min Kang
author_sort Minjae Yoon
title Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
title_short Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
title_full Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
title_fullStr Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
title_full_unstemmed Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
title_sort post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/550504f146ab437abc7137bee8ec93e6
work_keys_str_mv AT minjaeyoon posttransplantabsolutelymphocytecountpredictsearlycytomegalovirusinfectionafterhearttransplantation
AT jaewonoh posttransplantabsolutelymphocytecountpredictsearlycytomegalovirusinfectionafterhearttransplantation
AT kyeonghyeonchun posttransplantabsolutelymphocytecountpredictsearlycytomegalovirusinfectionafterhearttransplantation
AT chanjoolee posttransplantabsolutelymphocytecountpredictsearlycytomegalovirusinfectionafterhearttransplantation
AT seokminkang posttransplantabsolutelymphocytecountpredictsearlycytomegalovirusinfectionafterhearttransplantation
_version_ 1718392140638191616